Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Unaudited)

v3.23.1
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2021 $ 117,956   $ 230,543   $ (112,587)
Beginning balance, Shares at Dec. 31, 2021   28,927,129      
Stock-based compensation 1,811   1,811    
Net unrealized losses on available-for-sale securities (152)     $ (152)  
Issuance of common stock in connection with exercise of stock options 51   51    
Issuance of common stock in connection with exercise of stock options, Shares   50,000      
Net loss (12,946)       (12,946)
Ending balance at Mar. 31, 2022 106,720   232,405 (152) (125,533)
Ending balance, Shares at Mar. 31, 2022   28,977,129      
Beginning balance at Dec. 31, 2022 $ 104,520   270,129 (47) (165,562)
Beginning balance, Shares at Dec. 31, 2022 29,445,134 29,445,134      
Stock-based compensation $ 2,480   2,480    
Net unrealized losses on available-for-sale securities 47     $ 47  
Issuance of common stock in connection with exercise of stock options 458   458    
Issuance of common stock in connection with exercise of stock options, Shares   84,264      
Issuance of common stock under employee stock purchase plan, Shares   1,811,591      
Net loss (15,854)       (15,854)
Ending balance at Mar. 31, 2023 $ 91,651   $ 273,067   $ (181,416)
Ending balance, Shares at Mar. 31, 2023 31,340,989 31,340,989